Teton Advisors, Inc. Meridian Bioscience Inc Transaction History

Teton Advisors, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	BUY	$17.46 - $21.61 $26,190 - $32,415	1,500 Added 6.38%	25,000 $510,000
Q4 2020 Feb 05, 2021	SELL	$15.73 - $21.66 $23,595 - $32,490	-1,500 Reduced 6.0%	23,500 $439,000
Q3 2020 Nov 06, 2020	SELL	$13.54 - $26.41 $189,560 - $369,740	-14,000 Reduced 35.9%	25,000 $425,000
Q2 2020 Aug 13, 2020	SELL	$7.84 - $23.29 $325,360 - $966,535	-41,500 Reduced 51.55%	39,000 $908,000
Q1 2020 May 14, 2020	SELL	$5.57 - $11.5 $2,785 - $5,750	-500 Reduced 0.62%	80,500 $676,000
Q4 2019 Feb 14, 2020	SELL	$7.9 - $10.14 $110,600 - $141,960	-14,000 Reduced 14.74%	81,000 $791,000
Q3 2019 Nov 01, 2019	SELL	$9.17 - $12.01 $247,590 - $324,270	-27,000 Reduced 22.13%	95,000 $902,000
Q2 2019 Aug 02, 2019	SELL	$10.88 - $17.6 $130,560 - $211,200	-12,000 Reduced 8.96%	122,000 $1.45 Million
Q3 2018 Nov 02, 2018	SELL	$14.85 - $16.35 $311,850 - $343,350	-21,000 Reduced 13.55%	134,000 $2 Million
Q3 2017 Nov 01, 2017	BUY	$13.45 - $14.35 $2.08 Million - $2.22 Million	155,000	155,000 $2.22 Million

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Teton Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Teton Advisors, Inc. with notifications on news.